19 news items
U.S. Food and Drug Administration Approves Augtyro™ (repotrectinib), a Next-Generation Tyrosine Kinase Inhibitor (TKI), for the Treatment of Patients with NTRK-Positive Locally Advanced or Metastatic Solid Tumors
BMY
13 Jun 24
Society for Medical Oncology (ESMO). Epidemiology of cancers with NTRK gene fusion. Available
I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers
BMY
IMAB
5 Jun 24
. Collaboration builds on promising safety and efficacy data from the givastomig monotherapy study reported at the European Society of Medical Oncology
Bristol Myers Squibb Announces Opdivo (nivolumab) Plus Yervoy (ipilimumab) Significantly Improved Overall Survival Compared to Lenvatinib or Sorafenib as First-Line Treatment for Patients with Advanced Hepatocellular Carcinoma in CheckMate -9DW Trial
BMY
4 Jun 24
-breaking data to be presented at the 2024 American Society of Clinical Oncology (ASCO®) Annual
Bristol Myers Squibb's Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
BMY
3 Jun 24
in relapsed or refractory follicular lymphoma (FL).
The data, presented during the 2024 American Society
Bristol Myers Squibb Reveals Opdivo Results for Lung Cancer at ASCO 2024
BMY
3 Jun 24
and advanced non-small cell lung cancer (NSCLC). Data are being presented at the 2024 American Society of Clinical Oncology (ASCO®) Annual Meeting from May 31 to June 4, 2024, in Chicago, IL.
azpbe2yglax3zsyeha8imw
BMY
3 Jun 24
cancer (NSCLC). Data are being presented at the 2024 American Society of Clinical Oncology (ASCO®
my8bi3omtcpenntkfqdqmf2s mgp4ycvmvqx70ustiyu0f5s7dowb
BMY
3 Jun 24
in progression-free survival with KRAZATI compared to standard of care chemotherapy
Late-breaking data featured in an oral presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
8vj uuipz5j027sgfmmx1blcmdl8nmdslb
BMY
1 Jun 24
at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
wgdm1mb8d5756pmy475l74d3im31nuvexas17j uj03nv
AMGN
BMY
VSTM
24 May 24
pancreatic cancer.
The initial interim results will be presented at the upcoming American Society of Clinical Oncology Annual Meeting
ytg6gen5thr1lle2u3ep mluc40
BMY
23 May 24
) today announced the presentation of data across its oncology and hematology portfolio at the upcoming 2024 American Society of Clinical Oncology
06ldfk7vx6ixu3x3ueskpn839zi5j5zj61x91v
BMY
21 May 24
, but society often tells them that their diagnosis means they have to put their goals aside," said Jasmine Greenamyer, Vice President of Patient
bsaupc5zp30gopgxf997la5mc9hnt99jwxyc8v5xoo
BMY
CATX
LNTH
15 May 24
was informed by the investigator that updated results from 12 patients have been accepted for presentation at the Society of Nuclear Medicine
ojfsz3lj0alx14jc8p9oosje 3n6q
BMY
26 Apr 24
Society
4rczyqc6l0hcbqch4dumlko 31ay
ABBV
ATNM
AZN
19 Apr 24
Actinium's Phase 3 SIERRA trial results, recently unveiled at the 50th Annual European Bone Marrow Transplant Society Meeting
euk0x4zbgjv6zo096zgjalpoy979i a8rbdhxmqp8c0vd8lgs2am
ATNM
AZN
BMY
18 Apr 24
of the European Bone Marrow Transplant Society (EBMT) being held April 14 – 17, 2024, in Glasgow, Scotland. Iomab-B is a targeted radiotherapy conditioning
kydsvi2
ATNM
AZN
BMY
17 Apr 24
) access. These pivotal findings will be featured at the 50th Annual European Bone Marrow Transplant Society (EBMT) meeting in Glasgow, Scotland
zvr0pqsckotym0gh106h1xaqdf84ewy9d51eky71kiw8m5qfdievep6y762
BMY
6 Apr 24
) in Schizophrenia" (Poster F264) at the Annual Congress of the Schizophrenia International Research Society (SIRS) being held April 3-7, 2024, in Florence
thd7xs2iirlto9rt5cod9p10vp4jlyje79fzn
BMY
6 Apr 24
Studies EMERGENT-4 and EMERGENT-5" at the Annual Congress of the Schizophrenia International Research Society (SIRS) being held April 3-7, 2024
0678gr24vcas06kxaxucfegsi1m
BMY
CATX
LNTH
28 Mar 24
that were deemed unrelated to [212Pb]VMT-α-NET treatment.Further data readout has been submitted to Society of Nuclear
- Prev
- 1
- Next